NEW YORK (GenomeWeb) – Roche announced late yesterday that it has commenced a $2.2 debt tender offer.

The Swiss pharmaceuticals, diagnostics, and research products giant said that it launched an offer to purchase for cash the 5.25 percent Senior Notes due 2035 issued by its Genentech subsidiary and the 7 percent Senior Notes due 2039 issued by Roche Holdings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.